
    
      Patients with chronic migraine according to the criteria of the International Headache
      Society will be randomized to either active repetitive transcranial magnetic stimulation of
      the left dorsolateral prefrontal cortex or placebo repetitive transcranial magnetic
      stimulation, in a total of 23 sessions of treatment (15 sessions in the first month and 8
      sessions in the second month of treatment). Outcomes will be evaluated at baseline, after
      one, two months after treatment, and one month after end of treatment
    
  